Elite Pharmaceuticals Inc /Nv/ (ELTP)
CIK 1053369 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Elite Pharmaceuticals Inc /Nv/.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 10, 2026 | 4 | 0001324222-26-000001 |
| Aug 13, 2026 | 8-K | 0001493152-26-037787 |
| Aug 13, 2026 | 10-Q | 0001493152-26-037752 |
| Aug 11, 2026 | 8-K/A | 0001493152-26-036936 |
| Aug 10, 2026 | 8-K | 0001493152-26-036905 |
| Aug 4, 2026 | 8-K | 0001493152-26-035922 |
| Jun 29, 2026 | 8-K | 0001493152-26-031103 |
| Jun 29, 2026 | 10-K | 0001493152-26-031070 |
| Jun 23, 2026 | 8-K | 0001493152-26-029700 |
| Jun 15, 2026 | 8-K | 0001493152-26-028610 |
| Jun 1, 2026 | 8-K | 0001493152-26-026519 |
| Apr 2, 2026 | 8-K | 0001493152-26-014813 |
| Feb 17, 2026 | 8-K | 0001493152-26-007190 |
| Feb 17, 2026 | 10-Q | 0001493152-26-007104 |
| Feb 11, 2026 | 8-K | 0001493152-26-006213 |
| Jan 13, 2026 | 4 | 0001493152-26-002062 |
| Nov 14, 2025 | 8-K | 0001493152-25-023629 |
| Nov 14, 2025 | 10-Q | 0001493152-25-023477 |
| Oct 3, 2025 | 4 | 0001493152-25-016979 |
| Aug 26, 2025 | 4 | 0001493152-25-012347 |
| Aug 22, 2025 | 144 | 0001959173-25-005430 |
| Aug 14, 2025 | 8-K | 0001641172-25-024088 |
| Aug 14, 2025 | 10-Q | 0001493152-25-011989 |
| Aug 8, 2025 | 8-K | 0001493152-25-011765 |
| Jul 25, 2025 | 4 | 0001946043-25-000002 |